These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19709980)

  • 1. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
    Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
    Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
    Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
    J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.
    Friebe A; Horn M; Schmidt F; Janssen G; Schmid-Wendtner MH; Volkenandt M; Hauschild A; Goldsmith CH; Schaefer M
    Psychosomatics; 2010; 51(6):466-73. PubMed ID: 21051677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
    Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
    J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
    Capuron L; Ravaud A; Miller AH; Dantzer R
    Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.
    Capuron L; Ravaud A; Dantzer R
    J Clin Oncol; 2000 May; 18(10):2143-51. PubMed ID: 10811680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes.
    Greenberg DB; Jonasch E; Gadd MA; Ryan BF; Everett JR; Sober AJ; Mihm MA; Tanabe KK; Ott M; Haluska FG
    Cancer; 2000 Jul; 89(2):356-62. PubMed ID: 10918166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
    Maddock C; Baita A; Orrù MG; Sitzia R; Costa A; Muntoni E; Farci MG; Carpiniello B; Pariante CM
    J Psychopharmacol; 2004 Mar; 18(1):41-6. PubMed ID: 15107183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate for alpha-interferon induced depression.
    Camacho A; Ng B
    J Psychopharmacol; 2006 Sep; 20(5):687-9. PubMed ID: 16533869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
    Hauschild A; Weichenthal M; Rass K; Linse R; Ulrich J; Stadler R; Volkenandt M; Grabbe S; Proske U; Schadendorf D; Brockmeyer N; Vogt T; Rompel R; Kaufmann R; Kaatz M; Näher H; Mohr P; Eigentler T; Livingstone E; Garbe C
    J Clin Oncol; 2009 Jul; 27(21):3496-502. PubMed ID: 19433681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
    Schaefer M; Horn M; Schmidt F; Schmid-Wendtner MH; Volkenandt M; Ackenheil M; Mueller N; Schwarz MJ
    Brain Behav Immun; 2004 Nov; 18(6):555-62. PubMed ID: 15331126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
    Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
    Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
    Beratis S; Katrivanou A; Georgiou S; Monastirli A; Pasmatzi E; Gourzis P; Tsambaos D
    J Psychosom Res; 2005 Jan; 58(1):15-8. PubMed ID: 15771865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric complications associated with interferon-alpha-2b treatment of malignant melanoma.
    Okereke OI
    Psychosomatics; 2002; 43(3):237-40. PubMed ID: 12075040
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.
    Bannink M; Kruit WH; Van Gool AR; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
    Psychosomatics; 2008; 49(1):56-63. PubMed ID: 18212177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
    Alatrash G; Hutson TE; Molto L; Richmond A; Nemec C; Mekhail T; Elson P; Tannenbaum C; Olencki T; Finke J; Bukowski RM
    J Clin Oncol; 2004 Jul; 22(14):2891-900. PubMed ID: 15254058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
    Siegelmann-Danieli N; Bardo M; Law A; Fisk D; Bernath A
    Isr Med Assoc J; 2004 Oct; 6(10):636-7. PubMed ID: 15473596
    [No Abstract]   [Full Text] [Related]  

  • 19. Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients.
    Kovács P; Pánczél G; Balatoni T; Liszkay G; Gonda X; Bagdy G; Juhasz G
    J Psychosom Res; 2015 Jun; 78(6):579-84. PubMed ID: 25801845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.